Please use this identifier to cite or link to this item: http://hdl.handle.net/2440/14308
Citations
Scopus Web of ScienceĀ® Altmetric
?
?
Full metadata record
DC FieldValueLanguage
dc.contributor.authorSomogyi, A.en
dc.date.issued1997en
dc.identifier.citationAustralian Prescriber, 1997; 20(3):71en
dc.identifier.issn0312-8008en
dc.identifier.issn1839-3942en
dc.identifier.urihttp://hdl.handle.net/2440/14308-
dc.description.abstractIn the treatment of migraine, pethidine is less efficacious than dihydroergotamine plus metoclopramide: it can aggravate nausea, there is a risk of dependence and it has a short duration of effect necessitating additional medication. Its use therefore cannot be substantiated.en
dc.description.statementofresponsibilityAndrew A. Somogyien
dc.language.isoenen
dc.publisherAustralian Prescriberen
dc.source.urihttp://www.australianprescriber.com/magazine/20/3/artid/220/en
dc.subjectheadache; clinical trials; dependence; adverse effectsen
dc.titlePethidine is inappropriate for migraineen
dc.typeJournal articleen
dc.identifier.rmid0030003445en
dc.identifier.doi10.18773/austprescr.1997.061en
dc.identifier.pubid67451-
pubs.library.collectionPharmacology publicationsen
pubs.verification-statusVerifieden
pubs.publication-statusPublisheden
dc.identifier.orcidSomogyi, A. [0000-0003-4779-0380]en
Appears in Collections:Pharmacology publications

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.